Navigation Links
SC&H Capital Advises LSU Hospitals in Privatization Deal in Louisiana
Date:11/12/2013

Baltimore, MD (PRWEB) November 12, 2013

SC&H Capital, an investment banking and advisory firm focused on middle market and growth companies, served as the exclusive financial advisor to Louisiana State University Health Sciences Center at Shreveport (“LSUHSC-S” or the “Company”) in its public/private partnership with the Biomedical Research Foundation of Northwest Louisiana (“BRF”), with respect to two acute care facilities currently operated by LSUHSC-S. Specifically, the new partnership includes Shreveport Medical Center, a 459 bed hospital and E.A. Conway Medical Center, a 247 bed hospital in Monroe, Louisiana.

LSUHSC-S is northern Louisiana’s regional medical center and teaching hospital comprised of three acute care hospitals, LSU School of Allied Health Professionals, and LSU School of Graduate Studies. LSUHSC-S serves Louisiana as well as southwestern Arkansas, northeastern Texas, and parts of Oklahoma. In addition, LSUHSC-S is involved in a number of partnerships that have enabled it to bring highly sophisticated clinical services to the region.

Created in 1986 to diversify the regional economy, the Biomedical Research Foundation is northwest Louisiana's knowledge-based economic development initiative. With this partnership, the BRF will manage and operate two of the former LSU hospitals in Shreveport and Monroe through the BRF Hospital Holdings, LLC. (BRFHH), a nonprofit organization, and the new entities will be branded University Hospital. These two hospitals employ over 3,500 people and have an economic impact of approximately $900 million for north Louisiana.

LSU School of Medicine in Shreveport, which previously operated the hospitals, will remain a part of the public LSU System. The medical school traditionally received funding from the hospital in the past, but contracts with the BRF will replace that direct appropriation. “We have value in the doctors. We have services we need to exchange,” said Dr. Hugh Mighty, Vice Chancellor for Clinical Affairs at the Medical School. Dr. Mighty further noted, “SC&H Capital and i3 Healthcare Consulting provided the critical insights and advice to LSU which enabled this complex process to be successful for the multiple constituents involved; the educational leaders, government agencies, and several very concerned and involved communities”.

“In what was a highly complex process, which reflects the sophisticated nature of many of the joint ventures, M&A and partnership transactions being announced in the healthcare provider marketplace, we are excited and proud that SC&H provided the financial advisory services needed to bring this kind of deal to life,” said Kevin O’Sullivan, Senior Vice President, Investment Banking at SC&H Capital. “This deal, as many of our processes, required critical thinking, creativity and in-depth financial insights with the backdrop of alternative healthcare funding solutions. We look forward to working with our next provider client to create a great outcome.”

SC&H Capital and i3 Healthcare Consulting have partnered on several healthcare provider transactions.

About SC&H Capital
SC&H Capital, an affiliate of SC&H Group, LLC, is an investment banking and advisory firm focused on middle market and growth companies. SC&H Capital supports their investment banking activity with a full suite of strategic and financial resources to assist companies in the development and execution of strategic plans and initiatives. In conjunction with SC&H Group, LLC, SC&H Capital tailors their advisory services to ensure that their clients receive pertinent and valuable advice in every stage of the business life cycle – not just at the time of sale.

Securities offered through Stout Causey Capital Corporation, member FINRA/SIPC.

About i3 Healthcare Consulting
i3 Healthcare Consulting, LLC is a professional consulting services firm, based in Maryland, dedicated to serving healthcare organizations in the eastern U.S. I3’s approach is to serve their clients with integrity by delivering focused, high quality, innovative business consulting solutions that are integrated with the client's strategic, technologic, and financial goals and objectives. I3 offers expertise in strategy, revenue cycle, financial analysis, operational improvement and technology integration. They specialize in merging financial and operational experience with deep technology skills to help solve their client's business problems and deliver lasting results. The I3 vision is to build and maintain strong working relationships that have lasting benefits for their clients. This approach and focus bring sustainable results at a realistic cost.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11322254.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. SC&H Group Donates 84 Refurbished Laptop Computers to Children’s Guild and Arc Baltimore
2. SC&H Capital Advises iVantage in Acquisition of Professional Data Services
3. Medical Factoring and Finance Company Alleon Capital Partners Closes a Financing Facility with Lab Serving Dialysis Patients
4. Capital Health Regional Medical Center First and Only Hospital Named Both Joint Commission Top Performer and Joint Commission Advanced Comprehensive Stroke Center
5. Vopne Capital Launches $20 Million Buyout Fund
6. Real Food Works Receives Investment From First Round Capital and StartUp PHL’s Innovative City-Backed Fund
7. Grand Opening of Healthy Living Center Marks Advancement in Wellness for Capital Region
8. Capital Institute for Neurosciences Launches Alzheimer's Program; Specialized Center Provides Latest Technology, Care and Family Support
9. Financial Advisor Plano, TX and Financial Planner Plano, TX "Best of the Best" Awarded to VAL-Trust Capital Partners, LLC for Excellence by Follow Media Consulting, Inc.
10. Thailand’s Capital to Host the 14th World Gourmet Festival
11. NuvoH2O Engages Hickey Freihofner Capital for Strategic Financial Advisory Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... MEDI+SIGN®, a provider ... that a new solution for Emergency Departments (ED) has been added to their ... Emergency Department examination rooms, and with a simplified pallet of information available to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... with distinction by the Undersea and Hyperbaric Medical Society (UHMS), the leading authority ... care and patient safety. Only a few hospitals and facilities have earned this ...
(Date:12/8/2016)... ... December 08, 2016 , ... Seavest ... Property owned by an affiliate of Seavest, has won a prestigious national healthcare ... Chester County ambulatory care center (ACC) was named “Best New Development, MOBs and ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 KEY FINDINGS ... the largest share of the market in 2016 and ... dominance can be attributed to a large number of ... (US hold the largest share in the patient temperature ... benefits such as reducing loss of blood during surgeries, ...
(Date:12/8/2016)... 8, 2016 Research and Markets has announced ... Trends - Adhesion Type, Application, Usability - Forecast to 2025" ... , ... Market is poised to grow at a CAGR of around 3.2% ... market is witnessing include advancements in extracellular microelectrode arrays and intracellular ...
(Date:12/8/2016)... Quebec , Dec. 8, 2016  Valeant ... and TSX: VRX) ("Valeant") today announced positive results ... clinical study to assess the safety and efficacy ... the treatment of plaque psoriasis. ... subjects with moderate to severe psoriasis, IDP-118 showed ...
Breaking Medicine Technology: